On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...
Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...
“What’s your favourite scary movie?” Ghostface repeatedly asks his victims. Well, that’s a matter of preference, but if you (and possibly whoever’s donning the Scream franchise disguise ...
“Use of these data therefore not only spreads disinformation but also helps the political project of scientific racism—the misuse of science to promote the idea that racial hierarchies and ...
Coming off a heartbreaking loss to the Ravens, the Tampa Bay Buccaneers must quickly shift gears to take on the Atlanta Falcons on a short week. At stake is first place in the NFC South division ...
Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...
Marlborough-based Boston Scientific increased its estimated net sales growth for 2024. Meanwhile, Thermo Fisher slightly raised its full-year adjusted earnings per share guidance. Boston ...
The MedSurg division, which includes endoscopy, urology, and neuromodulation devices, had a 10% revenue rise to $1.48 billion. Boston Scientific Lowers FY EPS Outlook, Raises Adjusted EPS The ...
Boston Scientific (NYSE:BSX) shares were down 5% in morning trading Wednesday following news that the company has paused a study for its new FARAPULSE Pulse Field Ablation system due to unforeseen ...
JEAN DAWSON “Glimmer of God,” the just-released fourth full-length from this California singer, songwriter, and arranger, is full of ambition and nerve, blending influences from R&B, power ...